A detailed history of Archer Investment Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Archer Investment Corp holds 121 shares of NVO stock, worth $10,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Previous 101 19.8%
Holding current value
$10,571
Previous $14.5 Million 0.68%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $2,381 - $2,908
20 Added 19.8%
121 $14.4 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $1,735 - $2,310
-17 Reduced 14.41%
101 $13 Million
Q4 2023

Jan 30, 2024

BUY
$87.78 - $105.45 $1,492 - $1,792
17 Added 16.83%
118 $12.2 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $4,637 - $10,176
51 Added 102.0%
101 $9.17 Million
Q1 2023

May 09, 2023

BUY
$132.34 - $159.14 $6,617 - $7,956
50 New
50 $7.96 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.